Natural Capsules
add_icon

Natural Capsules

149.18
-0.65
(-0.43%)
Market Cap
154.27 Cr
PE Ratio
-8.13
Volume
3,42,560.00
Day High - Low
160.00 - 148.00
52W High-Low
296.00 - 144.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
154.27 Cr
EPS
0.23
PE Ratio
-8.13
PB Ratio
0.72
Book Value
218.35
EBITDA
18.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
0.24
Debt to Equity
0.49
Forecast For
Actual

Company News

View All News
Caret
neutral
Natural Capsules Limited announces Q3 FY25 results with total income of ₹122.98 crore and net profit of ₹49.33 crore. Company also reports nine-month performance data.
negative
Natural Capsules reported revenue of ₹37.75 crore in Q3FY26, down 18% QoQ and 14% YoY. EBITDA turned negative at ₹(2.33) crore with margins at (6.16%). Puducherry unit shutdown impacted operations.
positive
Natural Capsules Limited receives Madras High Court order suspending drug controller's temporary plant closure directive, allowing resumption of Pondicherry manufacturing operations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,784.50
#1 4,28,161.33
38.32
#1 54,729.00
9.71
#1 10,980
16.07
64.17
6,364.50
1,68,957.48
67.46
9,712.00
18.67
2,191
-1.02
54.62
4,353.40
1,47,338.84
64.68
11,539.40
6.99
1,911
26.24
64.72
1,313.50
1,09,628.70
19.51
33,741.20
16.73
5,725
-15.28
61.86
1,326.40
1,07,142.85
23.39
28,409.50
7.12
5,291
-57.18
42.94
2,332.90
1,06,566.59
22.56
22,909.50
13.74
3,306
#1 37.44
69.99
914.65
92,035.19
#1 17.95
23,511.00
18.55
4,615
-0.32
52.48
2,226.40
91,906.92
50.48
12,744.20
#1 20.90
2,007
7.65
59.92
1,225.50
71,177.24
19.92
32,345.60
9.43
3,484
7.59
58.16
5,550.00
66,358.58
26.96
13,458.30
3.70
2,216
1.90
47.80
Growth Rate
Revenue Growth
7.94 %
Net Income Growth
-89.29 %
Cash Flow Change
420.36 %
ROE
-90.12 %
ROCE
-35.08 %
EBITDA Margin (Avg.)
-22.82 %

Quarterly Financial Results

Quarterly Financials
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
15
14
15
16
16
14
16
17
16
19
19
22
23
26
30
38
42
44
45
46
38
38
38
41
41
39
41
44
45
46
46
38
Expenses
13
13
14
14
15
13
15
15
14
14
16
18
20
22
25
30
33
35
35
36
32
32
32
35
36
35
37
40
41
45
47
40
EBITDA
2
2
2
1
1
2
1
2
2
4
3
3
4
4
5
8
9
9
10
10
6
6
6
5
5
5
5
4
5
1
-1
-2
Operating Profit %
12 %
12 %
4 %
6 %
7 %
9 %
6 %
10 %
10 %
10 %
13 %
15 %
15 %
17 %
18 %
20 %
20 %
21 %
21 %
21 %
15 %
16 %
14 %
12 %
10 %
11 %
11 %
10 %
10 %
1 %
-2 %
-6 %
Depreciation
1
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
4
4
4
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
3
3
3
Profit Before Tax
1
1
0
0
1
0
0
0
0
3
2
2
2
3
4
6
7
7
7
7
3
3
2
2
1
1
1
1
1
-6
-8
-9
Tax
0
0
0
0
-0
0
0
0
0
1
0
1
1
1
1
2
2
2
2
2
1
1
1
1
1
0
1
0
0
-1
-1
-2
Net Profit
1
1
0
0
1
0
0
0
0
3
1
2
2
2
3
4
5
5
5
5
2
2
2
1
1
1
-1
0
1
-6
-7
-7
EPS in ₹
1.02
0.76
0.35
0.52
1.46
0.57
0.24
0.38
0.22
4.00
1.91
2.59
2.51
3.35
4.18
5.85
7.02
7.43
6.85
5.68
1.85
1.96
1.67
1.29
1.31
0.65
-0.60
0.10
0.13
-5.40
-6.76
-6.88

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
71
73
75
97
164
289
377
419
Fixed Assets
22
24
24
38
67
97
103
284
Current Assets
42
38
38
50
76
102
124
130
Capital Work in Progress
1
3
2
7
20
88
144
0
Investments
5
5
6
0
0
0
3
3
Other Assets
43
41
43
52
78
104
127
133
Total Equity & Liabilities
71
73
75
97
164
289
377
419
Current Liabilities
15
16
18
33
45
67
77
100
Non Current Liabilities
2
1
1
2
37
74
71
62
Total Equity
54
56
56
62
83
148
229
257
Reserve & Surplus
48
49
49
56
76
114
195
223
Share Capital
6
6
6
6
7
9
9
10

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-1
0
-0
1
0
1
-2
Investing Activities
-1
-7
-6
-9
-46
-105
-73
-45
Operating Activities
5
2
7
6
-1
17
-8
27
Financing Activities
-4
4
-1
3
48
88
82
16

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Nov 2024
Dec 2024
Feb 2025
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
54.37 %
54.37 %
54.38 %
56.58 %
56.57 %
56.57 %
56.56 %
56.56 %
56.56 %
56.56 %
56.56 %
56.56 %
56.56 %
56.56 %
51.60 %
51.14 %
51.14 %
51.14 %
51.21 %
51.26 %
51.26 %
51.26 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.22 %
1.31 %
1.31 %
0.00 %
1.31 %
0.00 %
1.31 %
0.18 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.22 %
32.02 %
32.21 %
30.54 %
32.10 %
33.38 %
34.09 %
34.81 %
35.09 %
35.11 %
35.17 %
35.13 %
34.72 %
35.10 %
32.26 %
32.85 %
32.86 %
32.86 %
33.09 %
33.04 %
32.94 %
32.95 %
Others
14.41 %
13.61 %
13.41 %
12.88 %
11.32 %
10.05 %
8.13 %
7.32 %
7.04 %
8.32 %
6.96 %
8.30 %
7.41 %
8.16 %
16.14 %
16.02 %
16.01 %
16.01 %
15.70 %
15.69 %
15.80 %
15.79 %
No of Share Holders
3,714
4,347
4,524
5,521
6,118
7,141
7,877
8,235
8,666
10,805
11,675
11,399
10,954
10,514
9,995
9,726
9,661
9,552
9,425
9,311
9,573
9,075

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Letter To Shareholders9 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot9 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 13, 2026
Announcement Under Regulation 30Feb 13, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 13, 2026
Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended December 31 2025.Feb 13, 2026
Board Meeting Outcome for Held On Friday February 13 2026.Feb 13, 2026
Board Meeting Intimation for Considering And Approving The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 31St December 2025.Feb 04, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Announcement Under Regulation 30(9) Of SEBI (LODR) Regulations 2015Jan 03, 2026
Announcement Under Regulation 30 Of SEBI( LODR) Regulations 2015Dec 26, 2025
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2025
Announcement Under Regulation 30Nov 13, 2025
Results For The Quarter And Half Year Ended 30Th September 2025Nov 13, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Board Meeting Intimation for Approval Of Un-Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2025Nov 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations 2015. Sep 30, 2025
Announcement under Regulation 30 (LODR)-RetirementSep 30, 2025
Closure of Trading WindowSep 26, 2025
Clarification With Respect To Significant Movement In The Price Of SecuritySep 23, 2025
Clarification sought from Natural Capsules LtdSep 22, 2025
Intimation Regarding 100 Days Campaign - Saksham NiveshakAug 21, 2025
Announcement under Regulation 30 (LODR)-Credit RatingAug 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 05, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 05, 2025
Authorised Persons For Determining And Disclosing Material Events & InformationAug 04, 2025
Authorised Persons For Determining And Disclosing Material Events & InformationAug 04, 2025
Financial Results For The Quarter Ended 30Th June 2025Aug 04, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 04, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 04, 2025
Board Meeting Intimation for For Approval Of The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 30Th June 2025.Jul 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025

Technical Indicators

RSI(14)
Neutral
34.03
ATR(14)
Volatile
11.40
STOCH(9,6)
Neutral
24.30
STOCH RSI(14)
Oversold
12.22
MACD(12,26)
Bearish
-0.54
ADX(14)
Weak Trend
11.52
UO(9)
Bearish
36.88
ROC(12)
Downtrend But Slowing Down
-7.20
WillR(14)
Oversold
-83.29